NCT01135303View on ClinicalTrials.gov

Effectiveness of VistaO2 Device in Screening of Sleep Apnea/Hypopnea Syndrome

NACompletedINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Sleep Apnea Syndromes
Interventions
DEVICE

VistaO2 device

Full night VistaO2 device monitoring synchronized with the gold standard polysomnography.

Trial Locations (2)

42055

CHU de Saint-Etienne, Saint-Etienne

75000

Hôpital TENON - APHP, Paris

Sponsors

Collaborators (1)

Novacor
All Listed Sponsors
collaborator

Novacor

UNKNOWN

lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER